These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-002272-41 A Multi-Centre, Single-Blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Duac Gel (A Gel containing Clindamycin Phosphate [Equivalent to 1% Clindamycin] and 5% Benzoyl Peroxide)... 2005-08-09 due-trials
Exempt 2004-004829-97 96 HOUR HUMAN PATCH TEST FOR ASSESSMENT OF PRIMARY SKIN IRRITATION 2005-02-11 not-yet-due
Exempt 2004-004830-15 Human Repeat Insult Patch Test with Challenge 2005-02-11 not-yet-due
Exempt 2005-000704-14 Human 96 Hour Repeat Open Application Test for Assessment of Skin Irritation not-yet-due
Not reported 2005-001371-35 A Double-Blind, Placebo Controlled, Half-Head Design, CPO Solution Dose Ranging-Finding Study in Patients with Seborrhoeic Dermatitis of the Scalp 2005-05-26 due-trials
No trial status on register 2005-002471-32 A PHASE II, SINGLE-CENTRE, INVESTIGATOR-BLIND, PARALLEL GROUP CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF 1% CICLOPIROX OLAMINE (BATRAFEN® CREAM), COMPARED TO 1% HYDROCORTISONE ACETATE (H... bad-data
Other 2005-004708-35 A Multi-Centre, Comparative, Randomized, Single-Blind, Parallel Group, Clinical Trial in Phase IV for the Evaluation of the Subjects Quality of Life, the Efficacy and the Tolerance of Duac® Gel (a Gel... not-yet-due
Exempt 2005-005897-54 A Phase 1, Single-Centre, Single-blind, CPO Solution Human Patch Test in Healthy Subjects 2006-02-10 not-yet-due
Not reported 2005-005905-51 A PHASE II, SINGLE CENTRE, RANDOMISED, PARALLEL GROUP, CLINICAL STUDY TO INVESTIGATE THE TOLERABILITY OF DOUBLE BLIND CICLOPIROX NAIL PRODUCT COMPARED TO DOUBLE BLIND PLACEBO NAIL PRODUCT COMPARED TO ... 2006-10-19 due-trials
Exempt 2005-005916-26 A phase I, single-blind, CPO solution human repeat insult patch test in healthy subjects. 2006-04-07 not-yet-due
Completed, but no date Terminated 2006-000292-15 A Phase II, Single-Centre, Randomised,Double-Blind, Parallel Group, CPO Solution, Dose Range Finding Study in Subjects with Seborrhoeic Dermatitis of the Scalp bad-data
No trial status on register 2007-002182-12 A SINGLE CENTER, SINGLE-BLIND, PARALLEL GROUP CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF W0153 VS. STANDARD MOISTURIZER IN THE MAINTENANCE OF PATIENTS WITH ATOPIC DERMATITIS bad-data
Not reported 2008-002359-26 A multi-center, randomized, evaluator-blind, parallel group study evaluation of the efficacy, safety, and tolerability of DUAC® Akne Gel and Epiduo® Gel in the topical treatment of facial acne vulga... 2009-04-28 due-trials
Not reported 2008-002418-23 A phase 2, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in subjects with distal subun... 2010-02-19 due-trials

Related organisations

Over time organisations can merge, or split.

We think Stiefel Laboratories is now effectively part of GlaxoSmithKline.